// App-Quantinova.ai

e14090 : Effects of MRX34, a liposomal miR-34 mimic, on target gene expression in human white blood cells (hWBCs): qRT-PCR results from a first-in-human trial of microRNA cancer therapy.

Researchers

Presenter

  • Heidi J. Peltier

Principal Investigators

  • Kevin Kelnar

  • Andreas G. Bader

Medical Centers

  • Mirna Therapeutics Inc, Austin, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • Solid malignancies

  • Mental retardation, X-linked 21

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • MRX34

Outcome

  • N/A

Study Design

  • First-In-Human

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved